chitosan has been researched along with Eye Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Peng, Q; Tang, X; Yan, R | 1 |
| Arafa, MG; El-Dahan, MS; Girgis, GNS | 1 |
| Jain, A; Jain, SK; Panda, PK; Saraf, S; Tiwari, A; Verma, A | 1 |
| Huang, S; Li, T; Xing, Y; Zhang, K; Zhu, L | 1 |
| Ban, J; Chen, Y; Deng, H; Du, Y; Hou, D; Huang, X; Lu, Z; Mo, Z; Shen, L; Wen, Y; Xie, Q; Zhang, S; Zhang, Y | 1 |
| Detsi, A; Pontillo, ARN | 1 |
| Chen, Q; Fan, L; Li, W; Qin, Z; Zhao, L; Zhao, M; Zhou, J | 1 |
| Chen, H; Li, X; Liang, R; Luo, Z; Shi, S; Yu, J; Zhang, Z | 1 |
| Agrahari, V; Mitra, AK; Pal, D; Sheng, Y; Trinh, HM; Yang, X | 1 |
| Kanwar, JR; Kanwar, RK; Ram, J; Sunkireddy, P | 1 |
| Alonso, MJ; de la Fuente, M; Paolicelli, P; Sánchez, A; Seijo, B | 1 |
| Alonso, MJ; de la Fuente, M; Paolicelli, P; Raviña, M; Sanchez, A; Seijo, B | 1 |
| Paliwal, R; Paliwal, SR; Vyas, SP; Wadhwa, S | 1 |
| Başaran, E; Yazan, Y | 1 |
| Gupta, H; Jain, S; Mathur, R; Mishra, AK; Mishra, P; Velpandian, T | 1 |
| Alonso, MJ; de la Fuente, M; Seijo, B | 1 |
6 review(s) available for chitosan and Eye Disorders
| Article | Year |
|---|---|
Carbohydrate polymer-based bioadhesive formulations and their potentials for the treatment of ocular diseases: A review.
Topics: Chitosan; Drug Delivery Systems; Eye; Eye Diseases; Humans; Hyaluronic Acid; Polymers | 2023 |
Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
Topics: Administration, Ophthalmic; Animals; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Eye; Eye Diseases; Humans; Nanoparticles; Nanotechnology; Pharmaceutical Preparations; Polylactic Acid-Polyglycolic Acid Copolymer | 2019 |
Chitosan nanoparticles for drug delivery to the eye.
Topics: Administration, Topical; Animals; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Compounding; Eye; Eye Diseases; Gene Transfer Techniques; Humans; Nanoparticles; Ophthalmic Solutions | 2009 |
Chitosan-based nanostructures: a delivery platform for ocular therapeutics.
Topics: Administration, Topical; Animals; Chitosan; Drug Delivery Systems; Epithelium, Corneal; Eye Diseases; Gene Transfer Techniques; Humans; Nanostructures | 2010 |
Chitosan and its role in ocular therapeutics.
Topics: Chitosan; Drug Delivery Systems; Eye Diseases; Gels; Humans; Liposomes; Nanoparticles; Polyelectrolytes; Polymers; Solubility | 2009 |
Ocular application of chitosan.
Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Eye Diseases; Gels; Humans; Nanoparticles; Ophthalmic Solutions; Pharmaceutical Preparations; Polymers | 2012 |
10 other study(ies) available for chitosan and Eye Disorders
| Article | Year |
|---|---|
Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium.
Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Biocompatible Materials; Biological Availability; Chitosan; Drug Carriers; Drug Delivery Systems; Eye Diseases; Gels; Inflammation; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits | 2020 |
Promising Antifungal Potential of Engineered Non-ionic Surfactant-Based Vesicles: In Vitro and In Vivo Studies.
Topics: Animals; Antifungal Agents; Cations; Chitosan; Drug Carriers; Drug Liberation; Eye Diseases; Hexoses; In Vitro Techniques; Liposomes; Mycoses; Particle Size; Rabbits; Surface-Active Agents | 2021 |
Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation.
Topics: Animals; Chitosan; Drug Carriers; Eye Diseases; Inflammation; Nanostructures; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Triamcinolone Acetonide | 2021 |
Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone.
Topics: Animals; Biological Availability; Chitosan; Cornea; Delayed-Action Preparations; Dexamethasone; Drug Carriers; Drug Liberation; Eye Diseases; Humans; Lipids; Nanostructures; Ophthalmic Solutions; Rabbits | 2018 |
Inhibitory effect of chitooligosaccharides on retinol metabolism and bioavailability in mice.
Topics: Acyltransferases; Animals; Chitin; Chitosan; Eye Diseases; Humans; Mice; Occupational Exposure; Oligosaccharides; Retinoic Acid 4-Hydroxylase; Retinol-Binding Proteins, Cellular; Retinol-Binding Proteins, Plasma; Risk; Vitamin A | 2019 |
Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.
Topics: Animals; Chitosan; Diclofenac; Drug Carriers; Eye Diseases; Humans; Male; Mice; Ophthalmic Solutions; Polyesters; Polyethylene Glycols; Rabbits | 2015 |
Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Topics: Administration, Ophthalmic; Administration, Topical; Biological Availability; Cell Line; Chemistry, Pharmaceutical; Chitosan; Corneal Keratocytes; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Emulsions; Eye Diseases; Gels; Humans; Hydrocortisone; Nanoparticles; Ocular Absorption; Particle Size; Poloxamer; Polyvinyl Alcohol | 2016 |
Ultra-small algal chitosan ocular nanoparticles with iron-binding milk protein prevents the toxic effects of carbendazim pesticide.
Topics: Animals; Apoptosis; Benzimidazoles; Carbamates; Cattle; Chitosan; Drug Delivery Systems; Eye Diseases; Humans; Iron-Binding Proteins; Lactoferrin; Milk Proteins; Nanoparticles; Oxidative Stress; Pesticides; Rats; Tissue Distribution | 2016 |
Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
Topics: Animals; Biological Availability; Chick Embryo; Chitosan; Chorioallantoic Membrane; Cornea; Delayed-Action Preparations; Drug Delivery Systems; Drug Packaging; Eye Diseases; Female; Gels; Goats; Hydrogen-Ion Concentration; Instillation, Drug; Male; Parabens; Poloxamer; Rabbits; Radionuclide Imaging; Temperature; Timolol; Toxicity Tests, Acute; Viscosity | 2007 |
Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue.
Topics: Animals; Biocompatible Materials; Biological Transport; Cells, Cultured; Chitosan; Conjunctiva; Cornea; DNA; Epithelium, Corneal; Eye Diseases; Genetic Therapy; Humans; Hyaluronic Acid; Male; Microscopy, Confocal; Models, Animal; Nanoparticles; Nanotechnology; Rabbits; Transfection | 2008 |